Fortress Biotech Unit Expands Gout Drug License Deal With Fuji Yakuhin to Include New Markets
11:03AM ET 12/14/2022 MT NewswiresFortress Biotech (FBIO) subsidiary Urica Therapeutics said Wednesday it has expanded its gout drug development license agreement with Fuji Yakuhin to...